Event Videos

https://pubmed.ncbi.nlm.nih.gov/35466492/ liver transplant
Pediatr Transplant. 2022 Apr 24;e14292.
doi: 10.1111/petr.14292. Online ahead of print.

Epstein-Barr virus-associated risk factors for post-transplant lymphoproliferative disease in pediatric liver transplant recipients

Jesus Quintero Bernabeu 1, Javier Juamperez 1, Maria Mercadal-Hally 1, Mauricio Larrarte King 1, Soledad Gallego Melcon 2, Luis Gros Subias 2, Constantino Sábado Álvarez 2, Pere Soler-Palacin 3, Susana Melendo Pérez 3, Juliana Esperalba 4, Alexandra Navarro Jiménez 5, Marta Garrido Pontnou 5, Jessica Camacho Soriano 5, Ernest Hidalgo Llompart 6, Itxarone Bilbao Aguirre 6, Itzarone Charco Torra 6

Abstract

Published on: 
Apr-2022

https://pubmed.ncbi.nlm.nih.gov/35446965/ Wilson

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2022 Apr 10;39(4):357-361.
doi: 10.3760/cma.j.cn511374-20201231-00926.

[Analysis of clinical phenotypes and ATP7B gene variants in 75 children patients with Wilson' s disease]

[Article in Chinese]

Pan Liu 1, Fengyu Che, Chang Shu, Yarong Li, Xiaoguai Liu

Abstract
Objective: To analyze the clinical phenotypes and ATP7B gene variants among children patients with Wilson' s disease from Northwestern China.

Methods: The clinical features and variants of the ATP7B gene among 75 children with hepatic Wilson' s disease were retrospectively analyzed.

Published on: 
Apr-2022

https://pubmed.ncbi.nlm.nih.gov/35460136/ liver transplant

Pediatr Transplant. 2022 Apr 22;e14298.
doi: 10.1111/petr.14298. Online ahead of print.

Predictors of portal vein complications after pediatric liver transplantation: A German center experience

Amr Badawy 1 2, Stefan M Brunner 1, Birgit Knoppke 3, Melanie Völkl 3, Henrik Junger 1, Martin Loss 1, Barbara Sinner 4, Veronika Huf 4 5, Dirk Grothues 3, Michael Melter 3, Hans J Schlitt 1

Abstract

Published on: 
Apr-2022

https://pubmed.ncbi.nlm.nih.gov/35444966/ NAFLD

Front Pediatr. 2022 Apr 4;10:846273.
doi: 10.3389/fped.2022.846273. eCollection 2022.

Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children

Yiyoung Kwon 1, Eun Sil Kim 1, Yon Ho Choe 1, Mi Jin Kim 1

Abstract
Background: The spectrum of non-alcoholic fatty liver disease (NAFLD) ranges from isolated hepatic steatosis to non-alcoholic steatohepatitis to fibrosis. We aimed to introduce useful biomarkers released during liver inflammation and fibrogenesis that are easy to use in outpatient clinic and adjust to children to evaluate each NAFLD stage without biopsy.

Published on: 
Apr-2022

https://pubmed.ncbi.nlm.nih.gov/35455620/ Covid-19

Children (Basel). 2022 Apr 18;9(4):575.
doi: 10.3390/children9040575.

Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A Monocentric Study

Antonietta Giannattasio 1, Marco Maglione 1, Carolina D'Anna 1, Stefania Muzzica 1, Serena Pappacoda 1, Selvaggia Lenta 1, Onorina Di Mita 1, Giusy Ranucci 1, Claudia Mandato 2, Vincenzo Tipo 1

Abstract

Published on: 
Apr-2022

https://pubmed.ncbi.nlm.nih.gov/35442241/ NAFLD

J Pediatr Gastroenterol Nutr. 2022 Apr 20.
doi: 10.1097/MPG.0000000000003461.Online ahead of print.

Insight into the Adolescent Patient Experience with Nonalcoholic Fatty Liver Disease

Sanita L Ley 1 2, Katherine M Kidwell 1 3, Tori R Van Dyk 4, Sarah Orkin 2 5, Cathleen Odar Stough 6, Taylor Howarth 1, Amy R Goetz 1 7, Stavra A Xanthakos 2 5, Kristin Bramlage 2 4, Marialena Mouzaki 2 5, Ana Catalina Arce-Clachar 2 5, Meg H Zeller 1 2

Abstract

Published on: 
Apr-2022

https://pubmed.ncbi.nlm.nih.gov/35442238/ Metabolic

J Pediatr Gastroenterol Nutr. 2022 Apr 20.
doi: 10.1097/MPG.0000000000003452.Online ahead of print
.
Long-term Sebelipase Alfa Treatment in Children and Adults With Lysosomal Acid Lipase Deficiency

Barbara K Burton 1, Alejandra Consuelo Sanchez 2, Maria Kostyleva 3, Ana Maria Martins 4, Sachin Marulkar 5, Florian Abel 5, Ivo Barić 6
Abstract

Objectives: Sebelipase alfa is approved for treatment of lysosomal acid lipase deficiency (LAL-D). This single-arm, open-label study (NCT02112994) evaluated sebelipase alfa efficacy and safety in patients with LAL-D.

Published on: 
Apr-2022

https://pubmed.ncbi.nlm.nih.gov/35442235/ Acute liver failure

J Pediatr Gastroenterol Nutr. 2022 Apr 20.
doi: 10.1097/MPG.0000000000003448.Online ahead of print
.
Outcomes Analyses of Pediatric Acute Liver Failure Subjects Listed for Liver Transplantation

Sakil S Kulkarni 1, Charles W Goss 2, Adeel S Khan 3, Michelle L Nadler 1, Janis M Stoll 1, Maria B Doyle 3, Yumirle P Turmelle 1, David A Rudnick 1 4

Abstract

Background: We characterized recent outcomes in US pediatric acute liver failure (PALF) subjects listed for liver transplantation (LT) using the Scientific Registry of Transplant Recipients (SRTR) database.

Published on: 
Apr-2022

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: